Skip to main content

Table 1 Patients clinical and hormonal characteristics

From: Freeze-all policy versus luteal phase support with low dose of human chorionic gonadotrophin for high-responder patients undergoing intracytoplasmic sperm injection on pregnancy outcomes: a retrospective cohort observational study

Clinical baseline characteristics

Group A (n = 78)

Group B (n = 65)

p-Value

Patients age in years

34.8 ± 4.3

34.6 ± 4.2

0.804

Patients BMI (kg/cm2)

22.7 ± 3.6

22.6 ± 4.5

0.792

Antral follicle count

25.1 ± 6.8

27.1 ± 10.1

0.256

Basal FSH (UI/L)

6.5 ± 1.3

6.5 ± 1.6

0.904

Basal LH (UI/L)

6.7 ± 3.3

7.5 ± 3.3

0.148

AMH (ng/mL)

6.8 ± 2.8

7.4 ± 5.4

0.285

    Progesterone level (ng/ml)

1.2 ± 0.23

1.1 ± 0.32

0.658

Causes of infertility

 PCOS

18 (23.07%)

14 (21.53%)

 

 Endometriosis

6 (7.69%)

5 (7.69%)

0.435

 Male factor

35 (44.87%)

28 (43.07%)

 

 Unexplained infertility

19 (24.35%)

18 (27.69%)

 
  1. Data are presented as mean (SD), number, and proportion (%). BMI, body mass index; FSH, follicle-stimulating hormone; LH, luteinizing hormone; AMH, anti-Mullerian hormone; PCOS, polycystic ovarian syndrome